Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Gains from Investment Securities (2022 - 2025)

Compass Therapeutics' Gains from Investment Securities history spans 4 years, with the latest figure at $399000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 315.62% to $399000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a N/A change, with the full-year FY2025 number at $16.4 million, up 164.04% from a year prior.
  • Gains from Investment Securities hit $399000.0 in Q4 2025 for Compass Therapeutics, down from $17.2 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for CMPX hit a ceiling of $17.2 million in Q3 2025 and a floor of $35000.0 in Q4 2023.
  • Historically, Gains from Investment Securities has averaged $5.0 million across 4 years, with a median of $4.9 million in 2022.
  • Biggest five-year swings in Gains from Investment Securities: crashed 99.35% in 2023 and later soared 315.62% in 2025.
  • Tracing CMPX's Gains from Investment Securities over 4 years: stood at $5.4 million in 2022, then crashed by 99.35% to $35000.0 in 2023, then skyrocketed by 174.29% to $96000.0 in 2024, then soared by 315.62% to $399000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for CMPX at $399000.0 in Q4 2025, $17.2 million in Q3 2025, and $4.5 million in Q2 2025.